The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Jones, Paul W.
Leidy, Nancy K.
Garcia Gil, Esther
Funding for this research was provided by:
Almirall S.A., Barcelona, Spain